Cargando…
Pathogenicity and Viral Shedding of MERS-CoV in Immunocompromised Rhesus Macaques
Middle East respiratory syndrome coronavirus (MERS-CoV) has recently emerged in the Middle East. Since 2012, there have been approximately 2,100 confirmed cases, with a 35% case fatality rate. Disease severity has been linked to patient health status, as people with chronic diseases or an immunocomp...
Autores principales: | Prescott, Joseph, Falzarano, Darryl, de Wit, Emmie, Hardcastle, Kath, Feldmann, Friederike, Haddock, Elaine, Scott, Dana, Feldmann, Heinz, Munster, Vincent Jacobus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816332/ https://www.ncbi.nlm.nih.gov/pubmed/29483914 http://dx.doi.org/10.3389/fimmu.2018.00205 |
Ejemplares similares
-
Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV–infected rhesus macaques
por: Falzarano, Darryl, et al.
Publicado: (2013) -
206: Transcriptional signatures of pathogenesis and successful type I interferon and ribavirin therapy in a rhesus macaque model of MERS-CoV infection
por: Rasmussen, Angela L., et al.
Publicado: (2013) -
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
por: de Wit, Emmie, et al.
Publicado: (2020) -
Foodborne Transmission of Nipah Virus in Syrian Hamsters
por: de Wit, Emmie, et al.
Publicado: (2014) -
Respiratory disease and virus shedding in rhesus macaques inoculated with SARS-CoV-2
por: Munster, Vincent J., et al.
Publicado: (2020)